Fundraising FoxFlorida Opportunity Fund — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
Crowded is a financial management platform for nonprofit organizations that combines banking, expense management, payment collection, fundraising, and compliance in one system.
FintechImpact & Social GoodSaaSNew York, US
Daniel Grunstein(Founder)inDarryl Gecelter(Founder)inHowie Schwartz(Chief Executive Officer)Mark Roth(Chief Operating Officer)
Co-investorsGaingelsMana VenturesWestern Technology InvestmentSarona Ventures
__Twitter.png)
Irys is a blockchain platform designed to store large volumes of data on-chain, enabling smart contracts to access it directly while providing proof of data persistence over time.
Crypto & Web3Data & Infrastructure
Josh Benaron(Founder)in
Co-investorsBreedHypersphere VenturesLemniscapCoinFundDeepWork CapitalFramework Ventures+2 more
Irys builds legal AI software for lawyers, using matter-aware intelligence, jurisdiction-grounded retrieval, and audit provenance to address citation accuracy and supervision requirements in legal practice.
AI & Machine LearningEnterprise SoftwareLegalTechSaaS
Devansh(Co-Founder & Head of AI)
Co-investors57Blocks CapitalDeepWork CapitalMarkd
Markd is a venture capital firm that invests in insurtech startups, backing founders building AI and emerging technologies, modern insurance distribution platforms, and solutions for underserved markets.
FintechInsurTech
Parker Beauchamp(Founder)in
Co-investorsStartup TNTDeepWork Capital
Myosin Therapeutics is a clinical-stage biotechnology company developing a new class of targeted therapies that act on molecular nanomotors such as nonmuscle myosin II to treat cancer and neurological diseases.
BiotechDeep TechMedical DevicesJupiter, US
Courtney Miller(Co-founder (Scientific Founder))inPatrick Griffin, Ph.D.(Director)Dave Adams(Director)Andrew Ritter(Director)Robert Finizio(Director)Theodore Kamenecka(Director)
Co-investorsDeepWork CapitalMayo Clinic Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.